Dr. Maki brings nearly 20 years of biotechnology and pharma business development expertise as Company rapidly advances its powerful LNP platform to deliver mRNA-based therapies MENLO PARK, Calif. & ...

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. The data come from 20 pharmas that had the highest R&D budgets in 2020, as ...

MM+M held its third in-person Media Summit at Convene in New York City on Wednesday. The daylong leadership conference touched on numerous topics relevant to medical marketers, pharma executives and ...

During a June 2025 trade mission to the United Kingdom and France, Virginia Economic Development Partnership leaders and then-Gov. Glenn Youngkin met with AstraZeneca officials. Thirty-three days ...

Silo Pharma, Inc., a biopharmaceutical company focused on developing innovative treatments for mental health and chronic pain, announced in a recent letter to shareholders that it expects to submit an ...

DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging its proprietary RADR ® artificial intelligence (AI) and machine learning (ML) ...

Bristol Myers Squibb (BMS) is the latest big pharmaceutical company to collaborate with Jiangsu Hengrui Pharmaceuticals, a Chinese drugmaker that has become a popular partner for international firms ...

Why more and more companies worldwide are embracing this planning process Suzanne is a content marketer, writer, and fact-checker. She holds a Bachelor of Science in Finance degree from Bridgewater ...

Royalty Pharma plc (NASDAQ:RPRX) said it has entered into a research and development co-funding agreement with Johnson & Johnson (NYSE:JNJ) valued at $500 million to support the development of ...